IDH exploring a possible dual listing on the Egyptian Exchange

(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that it is contemplating a possible dual listing of the Company’s ordinary shares on the Egyptian Exchange (“the EGX”).

Tap or click here to read the announcement on RNS or here to read the full announcement in pdf.

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its results for the year ended 31 December 2019, reporting revenues of EGP 2,226 million and a net profit of EGP 505 million for the year.

Tap or click here to read the announcement on RNS or here to read the full earnings release in pdf.

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its results for the year ended 31 December 2019, reporting revenues of EGP 2,226 million and a net profit of EGP 505 million for the year.

Tap or click here to read the announcement on RNS or here to read the full earnings release in pdf.

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its results for the year ended 31 December 2019, reporting revenues of EGP 2,226 million and a net profit of EGP 505 million for the year.

Tap or click here to read the announcement on RNS or here to read the full earnings release in pdf.

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(London) – As the novel coronavirus that causes the covid-19 illness continues to spread across the globe, Integrated Diagnostics Holdings (IDH) is closely monitoring the situation in our markets. We have begun implementing measures we believe are necessary to guarantee the safety of our people, of our patients, and of the communities in which we operate. IDH’s response to the spread of covid-19 is focused on two fronts: Staff and patient safety and crisis management and business continuity.

Click here to read the full release in pdf.

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(Cairo and London) – Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), IDHC on the London Stock Exchange, a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announces the launch of its new Egypt-based subsidiary “Wayak” to invest in data mining and artificial intelligence platforms. Wayak will leverage the Group’s patient database to capture new growth opportunities in the healthcare management space and offer targeted services to its customers.

With a database covering more than 13 million patients, of which c.10% suffer from chronic diseases, Wayak will allow IDH to build electronic medical records of patients and better cater to their needs with new value propositions. These include building patient healthcare profiles, home-delivery of medications, diagnostics testing reminders, referrals to service providers under IDH’s network with discounted prices as well as follow-up services, amongst others.

Wayak is a joint venture that is 94% owned by IDH and 6% owned by renowned data analytics scientist and angel investor Dr. Khaled Ismail through his angel investment fund HIMangel. Dr. Ismail will serve as the managing partner, acting as CEO for the first three years of Wayak’s operations. He previously served as the managing director of Intel Mobile Communications and was a senior advisor to the Egyptian Minister of Communications. Dr. Ismail holds a Ph.D. in electrical engineering from the Massachusetts Institute of Technology (MIT).

Commenting on the Joint Venture, Dr. Hend El Sherbini, Chief Executive Officer of IDH, said “Wayak falls directly in line with our strategy to diversify the Group’s services and capture growth opportunities in an underserved market with strong demand for quality healthcare services. Our unique position with a vast database of some 13 million patients and a nationwide presence through our 420+ branch network will allow us to create our own clinical profiles and leverage data analytics to build targeted services. The new venture will extract favourable synergies from IDH’s current business, and we expect the new services to drive additional pathology and radiology testing and create a new growing revenue base for IDH while enhancing overall patient experience.”

“We are also particularly pleased to be partnering up with Dr. Ismail who brings a wealth of executive and field experience in data analytics along with a track record of start-up successes. We look forward to working with him to help Wayak capture this incredible market opportunity and contribute to the improvement of Egypt’s healthcare system,” El Sherbini added.

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announces today its results for the six-month period ended 30 June 2019, reporting a 23% year-on-year increase in revenues to EGP 1,061 million

Tap or click here to read the announcement on RNS or here to read the full earnings release in pdf.

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announces its results for the year ended 31 December 2018, reporting a net profit of EGP 497 million on total revenues of EGP 1,921 million.

Tap or click here to read the announcement on RNS or here to read the full earnings release in pdf.

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(Cairo and London) – Integrated Diagnostics Holdings (“IDH” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announced today that it has appointed J.P. Morgan Cazenove as Corporate Broker.

-Ends-

 

About Integrated Diagnostics Holdings
IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Group’s core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan) and Echo-Scan (Nigeria). A long track record for quality and safety has earned the Company a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 1,400 diagnostics tests. From its base of 405 branches as of 30 June 2018, IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group’s expansion plans include acquisitions in new Middle Eastern and African markets where its model is well-suited to capitalise on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity with a Standard Listing on the Main Market of the London Stock Exchange (ticker: IDHC) since May 2015.

IDH’s forward-looking strategy rests on leveraging its established business model to achieve four key strategic goals, namely: (1) continue to expand customer reach; (2) increase the number of tests per patient; (3) expand into new geographic markets through selective, value-accretive acquisitions; and (4) introduce new medical services by leveraging the Group’s network and reputable brand position. Learn more at idhcorp.com.

 

Contacts
IDH +20 (0)2 3345 5530

Sherif El-Ghamrawi,
Investor Relations Director
+20 (0)10 0447 8699
sherif.elghamrawi@idhcorp.com

Hudson Sandler (International Media Relations)
+44 (0) 207 796 4133

Dan de Belder
Bertie Berger
idh@hudsonsandler.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

(London) – Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), IDHC on the London Stock Exchange, a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, will publish its results for the year ended 31 December 2018 on Thursday 21 March 2019 at 7 am GMT.

An analyst and investor presentation will be hosted at the offices of Hudson Sandler, 25 Charterhouse Square, EC1M 6AE at 2 pm GMT on Thursday 21 March 2019. A live audio webcast will be available on the Group’s website at www.idhcorp.com.

Please email idh@hudsonsandler.com if you would like to attend the presentation.

Contact

IDH +20 (0)2 3345 5530

Sherif El-Ghamrawi,
Investor Relations Director
+20 (0)10 0447 8699
sherif.elghamrawi@idhcorp.com

Hudson Sandler (International Media Relations)
+44 (0) 207 796 4133

Dan de Belder
Bertie Berger
idh@hudsonsandler.com

 

About Integrated Diagnostics Holdings
IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Group’s core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan) and Echo-Scan (Nigeria). A long track record for quality and safety has earned the Company a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 1,400 diagnostics tests. From its base of 405 branches as of 30 June 2018, IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group’s expansion plans include acquisitions in new Middle Eastern and African markets where its model is well-suited to capitalise on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity with a Standard Listing on the Main Market of the London Stock Exchange (ticker: IDHC) since May 2015.

IDH’s forward-looking strategy rests on leveraging its established business model to achieve four key strategic goals, namely: (1) continue to expand customer reach; (2) increase the number of tests per patient; (3) expand into new geographic markets through selective, value-accretive acquisitions; and (4) introduce new medical services by leveraging the Group’s network and reputable brand position. Learn more at idhcorp.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

The facility will be the largest of its kind in Georgia and the region with enough capacity to deliver high quality clinical and pathology tests to the country’s entire population

(Cairo and London) – Integrated Diagnostics Holdings (“IDH” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announced today that its Jordan-based subsidiary Biolab has entered into an agreement with Georgia Healthcare Group PLC (GHG) to establish a Mega Laboratory (Mega Lab) in the Georgian capital of Tbilisi.

Under the agreement, Biolab will provide GHG with (1) training and management services including the implementation of Biolab’s technological platforms and laboratory information management systems (LIMS) and (2) consultancy and support to achieve Joint Commission International Accreditation (JCI) for the Mega Lab within two years from the expected launch date.

Biolab will retain up to 10% equity ownership in the Mega Lab and will receive a fixed annual management fee and a share of annualized profits to cover costs and expenses, in addition to an annual service fee.

The 7,500 square meter, multi-disciplinary Mega Lab will be the largest of its kind in Georgia and the Caucasus region and will be equipped with state-of-the-art technology covering the full suite of clinical and pathology tests. The Mega Lab will initially serve GHG’s network of over 37 hospitals and 16 district polyclinics utilizing one-third of the facility’s capacity, with plans to develop a B2B network of healthcare providers outside the Group to reach full utilization.

Commenting on the agreement, IDH’s Chief Executive Officer Dr. Hend El Sherbini said:

“We are truly excited to be partnering up with Georgia’s leading healthcare group and help usher in a new level of service offering to the Georgian population as well as unlock Group-wide operational efficiencies for GHG. IDH’s decades-long experience and our position as the operators of the sole JCI-accredited Mega Labs in Egypt and Jordan allow us to provide the necessary know-how, technical training and systems to help this venture succeed. I wish to thank the team at GHG for placing their confidence in us, and I look forward to our Groups’ continuous collaboration and support.”

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

Integrated Diagnostics Holdings, a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, recently launched the rebranding of Echo-Lab, its radiology and laboratory service in Nigeria.
IDH aims to transform Echo-Lab into Nigeria’s market leading medical diagnostics brand. The Company also aims to provide accessible and good quality diagnostics services to patients and doctors in Nigeria and to build a world-class integrated diagnostics business and vastly enhance Nigeria’s healthcare offering.

Senior management at IDH were joined at the launch event by suppliers, doctors and corporate clients to hear about IDH’s plans for Echo-Lab and how they will directly impact the lives of patients.
The Nigerian healthcare market, which is driven by increasing urbanisation and evolution of disease patterns, is growing rapidly and there is significant existing demand to deliver additional value to customers.
On 1 December 2017 IDH and Man Capital LLP acquired a majority stake in Echo-Scan, in partnership with the International Finance Corporation (“IFC”). Over the coming year, Echo-Lab will refurbish and upgrade existing locations as well as significantly augment its number of branches. The Group will call on IDH’s more than four decades of experience in Africa’s medical diagnostics industry and Man Capital’s decades-long presence in West Africa to drive expansion, hiring, and institutionalisation at Echo-Lab.

Omar Bedewy, Chief Financial Officer for IDH, commented: “Our acquisition of Echo-Lab marks a significant milestone in IDH’s journey to become the go-to healthcare company in Africa and the Middle East. Nigeria, being Africa’s most populous country with approximately 196 million inhabitants and with a reputation for producing world-class doctors, represents enormous growth potential for the Company. Our aim is to create synergies for consumers, building on the strong relationships our customers have with our brands as well as the physicians who trust us to be part of their diagnostic and treatment plans.”

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

A strategic expansion that is set to transform IDH’s Egyptian operation into a one-stop-shop diagnostics service provider; the investment is planned to have limited impact on cashflows

Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, is set to launch a radiology business in Egypt.

IDH is building a national brand in Egypt with a service offering highly complementary to its existing pathology-focused medical diagnostics services

“Our expansion into a high-value, adjacent segment of our industry is a milestone in the development of IDH on par with the expansion into Africa that now sees operations in three countries outside Egypt contributing double-digit percentages to our top line,” said Dr. Hend El Sherbini, Chief Executive Officer of IDH.

“Our market in Egypt is growing in the double digits, and so is our top line. Today, more than 75% of customers surveyed by a third-party research provider indicate a preference for consolidated service offerings that feature both pathology and radiology — and there is significant existing demand for us to capture. Our expectation is that our pathology business will deliver new patients to our radiology business and that, in the fullness of time, having both services under one roof will also drive growth in our pathology test volumes.”

“Importantly, our expansion into the fragmented radiology market will be powered by the strong relationships between our brands and our millions of customers as well as the physicians who trust us to be part of their diagnostic and treatment plans,” El Sherbini noted.

Al Borg Scan will offer a full range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms and cath lab facilities. It will draw on Al Borg’s brand equity to position itself as a premium service provider offering the full range of imaging services using the latest technology and highly trained staff. Medical equipment suppliers for the new venture are global brand names including Siemens, Hitachi, GE Healthcare, and Fujifilm. The company will emphasize convenience with the rollout of its mobile app and website and reinforce its high-end brand positioning with a premium facility and atmosphere at each of its branches. The business will be led by a group of the nation’s most prominent radiologists with a track record at Egypt’s leading hospitals and radiology centers.

Up to 70% of the cost of the expansion into radiology is now in place through an EGP 130.5 million, eight-year facility from the Ahli United Bank of Egypt. The facility is ring-fenced to Al Borg with no guarantees from, or recourse on, IDH or any of its other subsidiaries. The balance of the investment is planned to be financed from the operating cashflows of Al Borg.

IDH delivered 29% top-line growth in the first quarter of 2018, performing 6.6 million tests (+8% compared to 1Q2017) for 1.7 million patients (+13% year-on-year), underscoring the health of its core business as Egypt recovers from a period of devaluation and high inflation. Nigeria is the company’s newest expansion market, making its first contribution to the Group’s consolidated revenues in 1Q2018. IDH is expected to announce 1H2018 results on 16 August 2018.

 

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email

Integrated Diagnostics Holdings and Man Capital partner with the International Finance Corporation to invest in Nigerias Echo-Scan  

  • Dynasty Group Holdings is a joint venture between Integrated Diagnostics Holdings and Man Capital LLP
  • Dynasty and the International Finance Corporation (“IFC”) have committed to invest significant capital in the business over the next four years
  • The strategy is to build a world-class integrated diagnostics business and vastly enhance Nigeria’s healthcare offering

 

Cairo, Egypt, 1 December 2017

Integrated Diagnostics Holdings (“IDH”), IDHC on the London Stock Exchange, the largest fully integrated private-sector provider of medical diagnostics services in Egypt, Jordan and Sudan, and Man Capital LLP (“Man Capital”), the investment arm of the Mansour Group, announced today their first investment in Nigeria’s promising healthcare industry.

The investment will see Dynasty Group (“Dynasty”), a joint venture that is 51% owned by IDH, partner with the International Finance Corporation (“IFC”), a member of the World Bank Group, to invest in Eagle Eye Echo-Scan Services Limited (“Echo-Scan”), a leading medical diagnostics business based in Nigeria.

The transaction will see Dynasty acquire a majority stake in Echo-Scan and assume management control of the company, while both Dynasty and the IFC will invest USD 25 million to expand Echo-Scan’s nationwide service offering, footprint, and quality standards. Over the coming year, Echo-Scan will refurbish and upgrade existing locations as well as significantly augment its number of branches.

Echo-Scan’s growing network of medical diagnostic laboratories is currently spread across 12 locations in six states. The investment from Dynasty and the IFC will help bring best-in-class medical diagnostic practices and technology to Nigeria, ensuring Echo-Scan delivers global-standard pathology and radiology services across Nigeria.

Dynasty will help service the significant demand for healthcare equipment and services in Nigeria, which is driven by increasing urbanisation and evolution of disease patterns in Africa’s most populous country. The Group will call on IDH’s more than four decades of experience in Africa’s medical diagnostics industry as well as Man Capital’s resources and the network of the wider Mansour Group, with its decades-long presence in West Africa, to drive expansion, hiring and institutionalisation at Echo-Scan.

Dynasty’s strategy is to build a leading diagnostics platform across the Middle East and Africa.

Dr. Hend El Sherbini, Chief Executive Officer of Integrated Diagnostics, said: “We are exceptionally pleased to be adding Nigeria, the continent’s largest and most populous country, to our platform as our fourth country of operations. I can think of no better partner with whom to do this than Man Capital, which matches our more than four decades of operating experience in the industry with similarly long experience working on the ground in West Africa. Nigeria’s healthcare industry shares multiple similarities with Egypt’s in the 1980s and 1990s in terms of structure, pace of development and the emerging disease profile of patients. This is an environment in which we know how to operate: We have done it before in Egypt, Sudan and Jordan. Dynasty’s goal is to transform Echo-Scan into Nigeria’s market leader by establishing and growing a brand that will be equally attractive to walk-in patients, to insurers and to corporate clients.”

IDH operates 377 branches across Egypt, Sudan and Jordan and served 4.7 million patients in the first nine months of 2017 with a comprehensive range of medical diagnostic services. The company serves both individual “walk-in” patients and patients on corporate and insurance contracts.

Mohamed Mansour, Founder and Chairman of Man Capital LLP, said: “Whilst Nigeria’s healthcare industry has been on our radar for a long time, this deal represents our first foray into healthcare. With its decades of industry experience, IDH is the ideal partner with whom to capture this very compelling opportunity. Echo-Scan has a stellar reputation and will significantly benefit from Dynasty’s world class expertise. For anyone ready to take a long-term investment view, the opportunity for growth and economies of scale are clear: With thousands of small clinics, hospitals, and diagnostic centres spread across 36 states, Nigeria’s healthcare market is extremely fragmented and poorly provided for. We are incredibly excited about working with our partners to create a leading integrated diagnostics platform both in Nigeria and, more broadly, across the Middle East and Africa.”

The Mansour Group and Man Capital have a significant presence in a dozen Sub-Saharan African countries, employing thousands of personnel and operating across multiple industries. The Group has maintained operations and investments in Nigeria for more than two decades and employs close to 1,000 people. Its investments span multiple industries across the entire country, including the heavy machinery, power, mining, oil and gas, tobacco, telecoms infrastructure, real estate and logistics sectors.

Eme Essien Lore, IFC Country Manager for Nigeria, commented: “The IFC has always been a supporter of expanding healthcare services delivery in markets where it operates. Today, we are extending our partnership with Echo-Scan and Dynasty Group and allowing for increased access to diagnostic services across Nigeria. The transaction not only reinforces the IFC’s commitment to the healthcare sector, but also enables the transfer of international knowhow and foreign direct investment into Nigeria.”

Dynasty Group was advised on the transaction by Stanbic Nigeria, UUBO Nigeria, KPMG Nigeria and Hogan Lovells.

 

—ENDS—

 

 

Media enquiries

Man Capital LLP

Kenzie Falcoz, kfalcoz@mancapllp.com

 

Maitland         +44 (0)20 7379 5151

James McFarlane, jmcfarlane@maitland.co.uk

Jais Mehaji, jmehaji@maitland.co.uk

 

About Integrated Diagnostics Holdings

IDH is the largest fully integrated private-sector medical diagnostics services provider in Egypt, Jordan and Sudan, comprehensively offering pathology and molecular diagnostics, genetics testing and basic radiology. IDH’s core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan). IDH is listed on the London Stock Exchange (ticker: IDHC) and was founded in 2012 by the merger of Al Borg and Al Mokhtabar, the most established diagnostics services brands in Egypt.

 

About Man Capital LLP

Man Capital is the Mansour Group’s investment arm and is headquartered in London. The Mansour Group is present in more than 100 countries, employs 60,000 people and has an annual turnover of more than US$ 6 billion.

 

About IFC

IFC, a member of the World Bank Group, is the largest global development institution focused on the private sector in emerging markets. Working with more than 2,000 businesses worldwide, we use our capital, expertise, and influence to create markets and opportunities in the toughest areas of the world. In FY17, we delivered a record $19.3 billion in long-term financing for developing countries, leveraging the power of the private sector to help end poverty and boost shared prosperity. For more information, visit www.ifc.org.

 

About Echo-Scan Limited

Echo-Scan is a network of medical diagnostic laboratories, providing radiology and pathology services, through more than a dozen branches distributed across Nigeria. Echo Scan has service locations in Kaduna, Abuja, Karu, Lagos, Asaba, Benin and Mararaba.

 

 

 

In the News

  • Sunday, 11 October 2020 - News

    DR. HEND EL SHERIBINI INTERVIEWED BY LIONESSES OF AFRICA

    IDH CEO Dr. Hend El Sherbini speaks to Lionesses of Africa about her entrepreneurial journey and the Group’s development story going from a single lab in Egypt in 1979 to the largest diagnostic provider in Egypt with over 450 points...

  • Thursday, 9 April 2020 - News

    Dr. Hend El Sheribini featured on the cover of Forbes Middle East

    IDH CEO Dr. Hend El Sherbini speaks to Forbes about the Group's readiness for Coronavirus testing in Egypt and IDH's plans for the future Read the full interview here.

  • Thursday, 17 January 2019 - News

    Dr. Hend El Sheribini Interviewed by Sky News

    IDH CEO Dr. Hend El Sherbini speaks to Sky News about the Group's development story from a single lab in 1979 to running over 400 branches across Egypt, Sudan, Jordan and Nigeria. Watch full interview here.

  • Thursday, 7 December 2017 - News

    Vice President of Finance and Strategy Appointment

    (Jersey) Integrated Diagnostics Holdings ("IDH" or "the Group"), IDHC on the London Stock Exchange, Egypt's largest fully integrated private-sector provider of medical diagnostics services, announced today the appointment of Omar Bedewy as Vice President Finance and Strategy. Mr. Bedewy has more than 16...

  • Thursday, 7 December 2017 - News

    Second Price Monitoring Extension

    A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more...

  • Sunday, 23 October 2016 - News

    Oxford Business Group Profiles Dr. Hend El Sherbini

    Interview: Hend El Sherbini How does listing on the stock market create benefits for Egyptian health care companies? HEND EL SHERBINI: We considered an initial public offering for quite some time before finally listing in 2015. In our case, we wanted to...

  • Thursday, 30 June 2016 - News

    The Powerful Egyptian Woman Behind A $700 Million IPO, And Her Advice To Other Women

    Few people, even in Egypt, have heard of Hend El Sherbini. But she last year pulled off an amazing feat with the help of Abraaj Group: In May, she led her lab company, Integrated Diagnostics Holdings, to an IPO on the London Stock...

  • Monday, 23 February 2015 - News

    Dr. Hend El Sherbini Named One of the 100 Most Powerful Arab Women 2015

    It has been a busy time for Dr Hend El Sherbini – CEO of Integrated Diagnostics Holding. In December last year, private equity firm Actis announced an investment for 21 percent of IDH – the largest private sector healthcare diagnostics...

Press Releases

  • Wednesday, 18 November 2020 - Press Release

    IDH exploring a possible dual listing on the Egyptian Exchange

    (Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...

Media Contact

xx Contact Name
Tel: xx Contact Number
E-mail: xx Contact Email